Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

248 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Liquid biopsy: from concept to clinical application.
Alix-Panabières C, Marchetti D, Lang JE. Alix-Panabières C, et al. Among authors: lang je. Sci Rep. 2023 Dec 7;13(1):21685. doi: 10.1038/s41598-023-48501-x. Sci Rep. 2023. PMID: 38066040 Free PMC article.
Diagnostic alignment to optimize inter-rater reliability among lung transplant pathologists.
Pavlisko EN, Neely ML, Wikenheiser-Brokamp KA, Fishbein GA, Litzky L, Farver CF, Pal P, He M, Illei PB, Deshpande C, Robien MA, Kirchner J, Frankel CW, Lang JE, Belperio JA, Palmer SM, Sweet SC; Clinical Trials and Organ Transplantation (CTOT)-47 consortium. Pavlisko EN, et al. Among authors: lang je. J Heart Lung Transplant. 2025 Feb;44(2):173-181. doi: 10.1016/j.healun.2024.10.007. Epub 2024 Oct 13. J Heart Lung Transplant. 2025. PMID: 39406318
Precision Oncology in Breast Cancer Surgery.
Abbasi AB, Wu V, Lang JE, Esserman LJ. Abbasi AB, et al. Among authors: lang je. Surg Oncol Clin N Am. 2024 Apr;33(2):293-310. doi: 10.1016/j.soc.2023.12.011. Epub 2024 Jan 9. Surg Oncol Clin N Am. 2024. PMID: 38401911 Review.
Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial-Efficacy and Biomarker Discovery.
Albain KS, Yau C, Petricoin EF, Wolf DM, Lang JE, Chien AJ, Haddad T, Forero-Torres A, Wallace AM, Kaplan H, Pusztai L, Euhus D, Nanda R, Elias AD, Clark AS, Godellas C, Boughey JC, Isaacs C, Tripathy D, Lu J, Yung RL, Gallagher RI, Wulfkuhle JD, Brown-Swigart L, Krings G, Chen YY, Potter DA, Stringer-Reasor E, Blair S, Asare SM, Wilson A, Hirst GL, Singhrao R, Buxton M, Clennell JL, Sanil A, Berry S, Asare AL, Matthews JB, DeMichele AM, Hylton NM, Melisko M, Perlmutter J, Rugo HS, Symmans WF, Van't Veer LJ, Yee D, Berry DA, Esserman LJ. Albain KS, et al. Among authors: lang je. Clin Cancer Res. 2024 Feb 16;30(4):729-740. doi: 10.1158/1078-0432.CCR-22-2256. Clin Cancer Res. 2024. PMID: 38109213 Free PMC article. Clinical Trial.
248 results